Clinuvel Pharmaceuticals Limited's total assets for Q2 2025 were AU$236.20M, an increase of 2.20% from the previous quarter. CLVLF total liabilities were AU$18.90M for the fiscal quarter, a -32.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.